Coussy, F., El-Botty, R., Château-Joubert, S., Dahmani, A., Montaudon, E., Leboucher, S., Morisset, L., Painsec, P., Sourd, L., Huguet, L., Nemati, F., Servely, J.-L., Larcher, T., Vacher, S., Briaux, A., Reyes, C., La Rosa, P., Lucotte, G., Popova, T., ... Marangoni, E. (2020). BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Science Translational Medicine, 12 (532). doi:10.1126/scitranslmed.aax2625
https://hdl.handle.net/2268/249408
